2,500 Shares of Series D Convertible Preferred Stock Warrants to Purchase 1,250,000 Shares of Common Stock SUNESIS PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 26th, 2017 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 26th, 2017 Company Industry Jurisdiction